Pomdoctor Statistics

Total Valuation

Pomdoctor has a market cap or net worth of $645.51 million. The enterprise value is $708.36 million.

Market Cap	645.51M
Enterprise Value	708.36M

Important Dates

The last earnings date was Wednesday, December 3, 2025, after market close.

Earnings Date	Dec 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Pomdoctor has 118.44 million shares outstanding. The number of shares has increased by 56.11% in one year.

Current Share Class	n/a
Shares Outstanding	118.44M
Shares Change (YoY)	+56.11%
Shares Change (QoQ)	-26.44%
Owned by Insiders (%)	21.83%
Owned by Institutions (%)	n/a
Float	46.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.03
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.17

Current Ratio	0.17
Quick Ratio	0.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.97

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-32.56%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	16.81%
Revenue Per Employee	$328,274
Profits Per Employee	-$133,239
Employee Count	156
Asset Turnover	7.33
Inventory Turnover	31.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	61.54
Average Volume (20 Days)	2,407,850

Short Selling Information

The latest short interest is 102,202, so 0.09% of the outstanding shares have been sold short.

Short Interest	102,202
Short Previous Month	34,969
Short % of Shares Out	0.09%
Short % of Float	0.22%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pomdoctor had revenue of $51.21 million and -$20.79 million in losses. Loss per share was -$0.55.

Revenue	51.21M
Gross Profit	7.21M
Operating Income	-3.64M
Pretax Income	-20.79M
Net Income	-20.79M
EBITDA	-3.62M
EBIT	-3.64M
Loss Per Share	-$0.55

Full Income Statement

Balance Sheet

The company has $802,226 in cash and $63.66 million in debt, giving a net cash position of -$62.85 million or -$0.53 per share.

Cash & Cash Equivalents	802,226
Total Debt	63.66M
Net Cash	-62.85M
Net Cash Per Share	-$0.53
Equity (Book Value)	-72.53M
Book Value Per Share	-8.61
Working Capital	-22.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.86 million and capital expenditures -$3,086, giving a free cash flow of -$2.90 million.

Operating Cash Flow	-2.86M
Capital Expenditures	-3,086
Free Cash Flow	-2.90M
FCF Per Share	-$0.02

Full Cash Flow Statement

Margins

Gross margin is 14.08%, with operating and profit margins of -7.11% and -40.59%.

Gross Margin	14.08%
Operating Margin	-7.11%
Pretax Margin	-40.59%
Profit Margin	-40.59%
EBITDA Margin	-7.07%
EBIT Margin	-7.11%
FCF Margin	n/a

Dividends & Yields

Pomdoctor does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-56.11%
Shareholder Yield	-56.11%
Earnings Yield	-3.22%
FCF Yield	-0.45%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pomdoctor has an Altman Z-Score of -72.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-72.63
Piotroski F-Score	3